Cite
Westphal K, Weinbrenner A, Giessmann T, et al. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clin Pharmacol Ther. 2000;68(1):6-12doi: 10.1067/mcp.2000.107579.
Westphal, K., Weinbrenner, A., Giessmann, T., Stuhr, M., Franke, G., Zschiesche, M., Oertel, R., Terhaag, B., Kroemer, H. K., & Siegmund, W. (2000). Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clinical pharmacology and therapeutics, 68(1), 6-12. https://doi.org/10.1067/mcp.2000.107579
Westphal, K, et al. "Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein." Clinical pharmacology and therapeutics vol. 68,1 (2000): 6-12. doi: https://doi.org/10.1067/mcp.2000.107579
Westphal K, Weinbrenner A, Giessmann T, Stuhr M, Franke G, Zschiesche M, Oertel R, Terhaag B, Kroemer HK, Siegmund W. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clin Pharmacol Ther. 2000 Jul;68(1):6-12. doi: 10.1067/mcp.2000.107579. PMID: 10945310.
Copy
Download .nbib